Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Africa”

930 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 930 results

Large-scale testing (Phase 3)Study completedNCT03923725
What this trial is testing

A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.

Who this might be right for
Plasmodium Falciparum Malaria (Uncomplicated)
University of Oxford 2,583
Not applicableUnknownNCT02199951
What this trial is testing

Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania

Who this might be right for
Malaria
INDEPTH Network 10,000
Not applicableStudy completedNCT05048472
What this trial is testing

East Africa Point of Care Viral Load Study

Who this might be right for
HIVViral LoadPoint of Care Monitoring
MRC/UVRI and LSHTM Uganda Research Unit 956
Testing effectiveness (Phase 2)WithdrawnNCT02462772
What this trial is testing

Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa

Who this might be right for
Human Immunodeficiency Virus
Centre for the AIDS Programme of Research in South Africa
Not applicableStudy completedNCT03630263
What this trial is testing

This Study Assessed the Impact of Diet on Gastric Emptying Time and Metabolic Flexibility

Who this might be right for
ObesityDiabetes Mellitus, Type 2Appetitive Behavior
Purdue University 32
Testing effectiveness (Phase 2)Study completedNCT01775475
What this trial is testing

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

Who this might be right for
AIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell LymphomaAIDS-related Diffuse Small Cleaved Cell Lymphoma+6 more
AIDS Malignancy Consortium 7
Not applicableStudy completedNCT04466488
What this trial is testing

Prevent TB: Choice Architecture for TPT Delivery

Who this might be right for
HIV/AIDSTuberculosis
Johns Hopkins University 50,798
Not applicableActive Not RecruitingNCT04298905
What this trial is testing

Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA

Who this might be right for
Adherence, PatientTBHIV/AIDS+1 more
Johns Hopkins University 62
Not applicableStudy completedNCT04772469
What this trial is testing

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

Who this might be right for
Human Immunodeficiency VirusAcquired Immunodeficiency SyndromeHIV Infections+5 more
University of California, San Francisco 934
Not applicableStudy completedNCT03500172
What this trial is testing

HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

Who this might be right for
HIV-1 Virologic Response
Johns Hopkins Bloomberg School of Public Health 1,391
Not applicableNot Yet RecruitingNCT07390409
What this trial is testing

ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.

Who this might be right for
HIV
Desmond Tutu HIV Foundation 3,700
Testing effectiveness (Phase 2)Study completedNCT04561063
What this trial is testing

COVID-19 Prophylaxis South Africa (COVER HCW)

Who this might be right for
Covid19SARS-CoV Infection
University of Witwatersrand, South Africa 1,950
Not applicableStudy completedNCT02124109
What this trial is testing

The Genetic Basis of Acquired Heart Disease in Africa

Who this might be right for
Rheumatic Heart DiseaseRheumatic FeverEndomyocardial Fibrosis+1 more
National Human Genome Research Institute (NHGRI) 736
Not applicableWithdrawnNCT01293656
What this trial is testing

Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)

Who this might be right for
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT02909712
What this trial is testing

Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania

Who this might be right for
MalariaPregnancy MalariaCardiotoxicity+2 more
London School of Hygiene and Tropical Medicine 201
Not applicableStudy completedNCT00639145
What this trial is testing

Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol

Who this might be right for
HIV InfectionsHIV PositivePregnant Women
Elizabeth Glaser Pediatric AIDS Foundation 600
Not applicableStudy completedNCT05862857
What this trial is testing

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1)

Who this might be right for
HIV/AIDS
University of California, San Francisco 9,375
Not applicableNot Yet RecruitingNCT07506967
What this trial is testing

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

Who this might be right for
Skin and Connective Tissue DiseasesNeglected Tropical DiseasesLeprosy+10 more
Kenya Medical Research Institute 2,420
Large-scale testing (Phase 3)Study completedNCT02699099
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 699
Post-approval studies (Phase 4)Study completedNCT01088516
What this trial is testing

Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa

Who this might be right for
HIV
University of Zambia 280
Next Page